334.75 USD
-0.08 (-0.02%)
334.8 USD
+0.05 (+0.01%)
ChartMill assigns a Buy % Consensus number of 54% to SWAV. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 330.75. This target is -1.19% below the current price.
SWAV was analyzed by 16 analysts. The buy percentage consensus is at 54. So analysts seem to be rather neutral about SWAV.
In the last month the buy percentage fell by 15 points. So the trust of analysts is decreasing.
SWAV was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-08 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-04-08 | CL King | Downgrade | Buy -> Neutral |
| 2024-04-08 | Deutsche Bank | Downgrade | Buy -> Hold |
| 2024-04-08 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2024-04-05 | Wolfe Research | Downgrade | Outperform -> Peer Perform |
| 2024-04-05 | Needham | Downgrade | Buy -> Hold |
| 2024-04-05 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2024-04-02 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-03-27 | CL King | Initiate | Buy |
| 2024-02-16 | Needham | Maintains | Buy -> Buy |
| 2024-02-16 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-02-16 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-12-04 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-11-07 | Needham | Maintains | Buy -> Buy |
| 2023-11-07 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-10-24 | Needham | Maintains | Buy -> Buy |
| 2023-10-16 | Leerink Partners | Initiate | Outperform |
| 2023-09-29 | UBS | Initiate | Neutral |
| 2023-08-10 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-08-08 | Needham | Maintains | Buy -> Buy |
| 2023-08-08 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2023-07-10 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2023-05-09 | Deutsche Bank | Maintains | Buy |
| 2023-05-09 | Needham | Maintains | Buy |
| 2023-05-09 | Oppenheimer | Reiterate | Underperform |
| 2023-05-09 | Wells Fargo | Maintains | Equal-Weight |
| 2023-05-09 | Canaccord Genuity | Maintains | Buy |
| 2023-05-09 | Morgan Stanley | Maintains | Equal-Weight |
| 2023-05-09 | Piper Sandler | Maintains | Overweight |
| 2023-04-11 | Needham | Maintains | Buy |
SHOCKWAVE MEDICAL INC / SWAV FAQ
What is the price target for SWAV stock?
16 analysts have analysed SWAV and the average price target is 330.75 USD. This implies a price decrease of -1.19% is expected in the next year compared to the current price of 334.75.
What is the consensus rating for SHOCKWAVE MEDICAL INC (SWAV) stock?
The consensus rating for SHOCKWAVE MEDICAL INC (SWAV) is 53.75 / 100 . This indicates that analysts generally have a neutral outlook on the stock.